Cardiac symptom burden and arrhythmia recurrence drives digital health use: results from the iHEART randomized controlled trial.
Ruth Marie Masterson CreberMeghan Reading TurchioeAngelo BivianoBilly A CaceresHasan GaranIsaac GoldenthalTheresa KoleckShazia MithaKathleen HickeySuzanne R BakkenPublished in: European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology (2021)
Frequent use of AliveCor® is associated with AF symptoms and potentially symptomatic cardiac events. Symptom burden and frequency should be measured and incorporated into analyses of future digital health trials for AF management.